Atlas Trials

Safety and Efficacy Study of Viaskin Peanut in Peanut-allergic Young Children 1-3 Years of Age

Clinical trial NCT03211247 · COMPLETED

Trial details

NCT number
NCT03211247
Sponsor
DBV Technologies
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Peanut Allergy
Start date
2017-07-31
Primary completion
2019-08-20
Enrollment
414

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.